Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1917139rdf:typepubmed:Citationlld:pubmed
pubmed-article:1917139lifeskim:mentionsumls-concept:C0040669lld:lifeskim
pubmed-article:1917139lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:1917139lifeskim:mentionsumls-concept:C0020205lld:lifeskim
pubmed-article:1917139lifeskim:mentionsumls-concept:C0086661lld:lifeskim
pubmed-article:1917139lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:1917139lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:1917139lifeskim:mentionsumls-concept:C1522685lld:lifeskim
pubmed-article:1917139lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:1917139pubmed:issue3lld:pubmed
pubmed-article:1917139pubmed:dateCreated1991-10-30lld:pubmed
pubmed-article:1917139pubmed:abstractTextIn a mouse plasmacytoma S194, c-myc oncogene is rearranged with Ig gene by chromosomal translocation and is consequently activated. We previously reported that transformation of phenotype and expression of rearranged c-myc were repressed in independently isolated hybrid clones, I-1 and IV-10, between S194 and normal fibroblasts. In order to investigate the relationship between transformation of phenotype and oncogene expression, transcriptionally enhanced c-myc or activated c-Ha-ras was transfected into I-1 or IV-10I, a subclone of IV-10. Transfectants expressing high levels of c-myc were found to retain the non-transformed phenotypes. On the other hand, transfectants expressing activated c-Ha-ras showed the transformed phenotypes. These results suggest that enhanced expression of c-myc is not sufficient for re-transformation of the non-transformed hybrid clones between c-myc-activating plasmacytoma cells and normal fibroblasts, but expression of activated c-Ha-ras could diminish or overcome the tumor-suppressive activity of normal fibroblasts.lld:pubmed
pubmed-article:1917139pubmed:languageenglld:pubmed
pubmed-article:1917139pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1917139pubmed:citationSubsetIMlld:pubmed
pubmed-article:1917139pubmed:statusMEDLINElld:pubmed
pubmed-article:1917139pubmed:monthSeplld:pubmed
pubmed-article:1917139pubmed:issn0020-7136lld:pubmed
pubmed-article:1917139pubmed:authorpubmed-author:KuzumakiNNlld:pubmed
pubmed-article:1917139pubmed:authorpubmed-author:OikawaTTlld:pubmed
pubmed-article:1917139pubmed:authorpubmed-author:SatohCClld:pubmed
pubmed-article:1917139pubmed:authorpubmed-author:KondohNNlld:pubmed
pubmed-article:1917139pubmed:issnTypePrintlld:pubmed
pubmed-article:1917139pubmed:day30lld:pubmed
pubmed-article:1917139pubmed:volume49lld:pubmed
pubmed-article:1917139pubmed:geneSymbolc-myclld:pubmed
pubmed-article:1917139pubmed:geneSymbolc-Ha-raslld:pubmed
pubmed-article:1917139pubmed:ownerNLMlld:pubmed
pubmed-article:1917139pubmed:authorsCompleteYlld:pubmed
pubmed-article:1917139pubmed:pagination403-8lld:pubmed
pubmed-article:1917139pubmed:dateRevised2007-7-24lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:meshHeadingpubmed-meshheading:1917139-...lld:pubmed
pubmed-article:1917139pubmed:year1991lld:pubmed
pubmed-article:1917139pubmed:articleTitleRe-transformation of non-transformed hybrids between c-myc-activating mouse plasmacytoma cells and normal fibroblasts by transfection with activated c-Ha-ras but not c-myc.lld:pubmed
pubmed-article:1917139pubmed:affiliationCancer Institute, Hokkaido University School of Medicine, Sapporo, Japan.lld:pubmed
pubmed-article:1917139pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1917139pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed